If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorkspace Regulatory News (WKP)

Share Price Information for Workspace (WKP)

Share Price is delayed by 15 minutes
Get Live Data
335.00    -10.00 (-2.90%)
Bid:
334.20
Ask:
335.20
Spread: 1.00 (0.299%)
Market Cap: £645.37m
WKP Live PriceLast checked at - London Stock Exchange

Intraday Workspace Share Chart

Form 8.3 - McKay Securities plc

3 May 2022 16:39

RNS Number : 1709K
Barclays PLC
03 May 2022
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

 

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

 

MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MCKAY SECURITIES PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

29 April 2022

(f)

In addition to the company in 1(c) above, is the discloser making

YES:

disclosures in respect of any other party to the offer?

WORKSPACE GROUP PLC

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing (if any)

Class of relevant security:

20p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

0

0.00%

0

0.00%

(2)

Cash-settled derivatives:

0

0.00%

1,388,860

1.54%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

0

0.00%

1,388,860

1.54%

(b)

Rights to subscribe for new securities (including directors and other executive

 

options)

 

Class of relevant security in relation to

 

which subscription right exists

 

Details, including nature of the rights

 

concerned and relevant percentages:

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

 

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

20p ordinary

 SWAP

Long

2,042

2.8211 GBP

20p ordinary

 SWAP

Long

2,681

2.8197 GBP

20p ordinary

 CFD

Short

32,756

2.8464 GBP

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the person making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

3 May 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSSWFIDEESEDI
Date   Source Headline
31st Aug 20232:27 pmRNSHolding(s) in Company
29th Aug 20239:19 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSNOTICE OF RESULTS
25th Jul 20234:46 pmRNSHolding(s) in Company
19th Jul 202311:22 amRNSDirector/PDMR Shareholding
10th Jul 20234:33 pmRNSDirector/PDMR Shareholding
6th Jul 20231:39 pmRNSCommittee Changes
6th Jul 20231:34 pmRNSRESULTS OF ANNUAL GENERAL MEETING
6th Jul 20237:00 amRNSQ1 Business Update
3rd Jul 202310:10 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jun 20235:11 pmRNSVoting Rights and Share Capital
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
28th Jun 20235:36 pmRNSHolding(s) in Company
26th Jun 20233:18 pmRNSDirector/PDMR Shareholding
26th Jun 20231:24 pmRNSDirector/PDMR Shareholding
26th Jun 20239:35 amRNSDirector/PDMR Shareholding
22nd Jun 20232:22 pmRNSDirector/PDMR Shareholding
20th Jun 202311:55 amRNSDirector/PDMR Shareholding
19th Jun 202310:24 amRNSDirector/PDMR Shareholding
14th Jun 20239:52 amRNSHolding(s) in Company
12th Jun 202312:27 pmRNS2023 Annual Report & Notice of 2023 AGM
25th May 20237:00 amRNSWORKSPACE GROUP PLC FULL YEAR RESULTS
16th May 20237:00 amRNSMcKay Disposal & Update
9th May 20237:00 amRNSRule 19.6(c) Confirmation
13th Apr 20237:00 amRNSSTRONG FOURTH QUARTER TRADING PERFORMANCE
11th Apr 20231:37 pmRNSDirector Declaration
15th Mar 20232:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSWORKSPACE COMPLETES DISPOSAL OF RIVERSIDE
1st Mar 20231:43 pmRNSHolding(s) in Company
28th Feb 20237:00 amRNSChairman Succession
19th Jan 20237:00 amRNSWorkspace Group Plc Third Quarter Business Update
3rd Jan 20239:31 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Nov 20225:39 pmRNSHolding(s) in Company
23rd Nov 202212:10 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSWORKSPACE GROUP PLC HALF YEAR RESULTS
17th Oct 20221:47 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSWORKSPACE GROUP PLC 2Q BUSINESS UPDATE
10th Oct 202211:30 amRNSBlocklisting Application
27th Sep 20223:34 pmRNSHolding(s) in Company
1st Sep 202211:50 amRNSDirector/PDMR Shareholding
18th Aug 20229:34 amRNSHolding(s) in Company
11th Aug 20229:40 amRNSHolding(s) in Company
26th Jul 20227:00 amRNSDISPOSAL OF NEWBURY MEDICAL CENTRE
21st Jul 20223:17 pmRNSRESULTS OF ANNUAL GENERAL MEETING
21st Jul 20227:00 amRNSFIRST QUARTER BUSINESS UPDATE
4th Jul 202211:49 amRNSHolding(s) in Company
1st Jul 202211:03 amRNSBLOCK LISTING SIX MONTHLY RETURN
27th Jun 20223:52 pmRNSDirector/PDMR Shareholding
27th Jun 20221:45 pmRNSDirector/PDMR Shareholding
27th Jun 202212:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.